Zheni Stavre is a Rheumatology/Immunology physician affiliated with University of Massachusetts Chan Medical School. OpenAlex indexes 8 publications with 1,336 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
119 Belmont St
Worcester, MA 016052903
Telephone
508-334-5224Provider last certified this registry record 30 Oct 2020.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- UCB, Inc.Program year20253 payments
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- Janssen Biotech, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
30.5%Folate Analog Metabolic Inhibitor18%Methotrexate100%Part D≥42 patientsInterleukin-17A Antagonist4.2%Taltz Autoinjector58%Cosentyx Sensoready (2 Pens)42%Part D<11 patients+ 3 more classes in this area
Musculoskeletal
22%Xanthine oxidase inhibitor8.6%Allopurinol69%Febuxostat31%Part D<11 patientsAlkaloid6.7%Colchicine100%Part D≥19 patients+ 2 more classes in this area
Metabolism & gastrointestinal
16%Corticosteroid13.8%Prednisone100%Part D≥38 patientsAminosalicylate2.1%Sulfasalazine Dr100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- What Are the On‐Ramps to Predict Psoriatic Arthritis? Does Monitoring C‐Reactive Protein Levels Help?
Arthritis Care & Research
2025 - Schnurri-3 inhibition suppresses bone and joint damage in models of rheumatoid arthritis
Proceedings of the National Academy of Sciences
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Fernando Martinez, MD
University of Massachusetts Chan Medical School
Kimberly Yonkers, MD
University of Massachusetts Chan Medical School
Xiaoduo Fan, MD
University of Massachusetts Chan Medical School
Joel Gore, MD
University of Massachusetts Chan Medical School
Marc Hochberg, MD
University of Maryland School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Dinesh Khanna, MD
University of Michigan
Matthew Liang, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”